89Zr-DFO-REGN5054

REGN5054 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-DFO-REGN5054, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab [Phase 1]

See pricing